zotatifin
effector therapeutics
['eft226', 'breast', 'zotatifin', 'effector therapeutics']
effector therapeutics reports positive interim results in zotatifin (eft226) phase 1/2 clinical trial at asco 2022 showing safety and tolerability, and initial signals of clinical activity - partial responses observed in heavily pre-treated er+ breast c... 
CEO Of Digital Media Online